Castleford Capital invests in growing pharmaceutical development and tech enabled healthcare services companies. Castleford backs management teams with capital, relationships and operational resources that empower leadership to attain new levels of growth. Castleford focuses on lower middle market companies including CROs, CDMOs, PBMs, pharmacy services, RCM, and tech-enabled healthcare solutions. Revelstoke Capital Partners is a middle-market healthcare private equity firm with $1.5 billion in assets under management. Revelstoke is led by experienced investors with a track record of building exceptional industry leading companies.